Abstract
Summary
The IVD product portfolio includes devices that assist in clinical chemistry & immunoassays, urinalysis, point-of-care testing, and patient self-testing devices.
LPI (LP Information)' newest research report, the “Lab Automation for In-vitro Diagnostics Industry Forecast” looks at past sales and reviews total world Lab Automation for In-vitro Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Lab Automation for In-vitro Diagnostics sales for 2023 through 2029. With Lab Automation for In-vitro Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lab Automation for In-vitro Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Lab Automation for In-vitro Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lab Automation for In-vitro Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Lab Automation for In-vitro Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lab Automation for In-vitro Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lab Automation for In-vitro Diagnostics.
The global Lab Automation for In-vitro Diagnostics market size is projected to grow from US$ 5014.1 million in 2022 to US$ 8437.5 million in 2029; it is expected to grow at a CAGR of 8437.5 from 2023 to 2029.
United States market for Lab Automation for In-vitro Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Lab Automation for In-vitro Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Lab Automation for In-vitro Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Lab Automation for In-vitro Diagnostics players cover Cognex Corporation, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies, Inc, Abbott, PerkinElmer, Inc, Tecan Group Ltd and BD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Lab Automation for In-vitro Diagnostics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Automated Plate Handler
Automated Liquid Handler
Robotic Arm
Others
Segmentation by application
Academic
Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cognex Corporation
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc
Danaher Corporation
Agilent Technologies, Inc
Abbott
PerkinElmer, Inc
Tecan Group Ltd
BD
Siemens
Key Questions Addressed in this Report
What is the 10-year outlook for the global Lab Automation for In-vitro Diagnostics market?
What factors are driving Lab Automation for In-vitro Diagnostics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lab Automation for In-vitro Diagnostics market opportunities vary by end market size?
How does Lab Automation for In-vitro Diagnostics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Lab Automation for In-vitro Diagnostics Industry Forecast” looks at past sales and reviews total world Lab Automation for In-vitro Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Lab Automation for In-vitro Diagnostics sales for 2023 through 2029. With Lab Automation for In-vitro Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lab Automation for In-vitro Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Lab Automation for In-vitro Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lab Automation for In-vitro Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Lab Automation for In-vitro Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lab Automation for In-vitro Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lab Automation for In-vitro Diagnostics.
The global Lab Automation for In-vitro Diagnostics market size is projected to grow from US$ 5014.1 million in 2022 to US$ 8437.5 million in 2029; it is expected to grow at a CAGR of 8437.5 from 2023 to 2029.
United States market for Lab Automation for In-vitro Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Lab Automation for In-vitro Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Lab Automation for In-vitro Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Lab Automation for In-vitro Diagnostics players cover Cognex Corporation, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies, Inc, Abbott, PerkinElmer, Inc, Tecan Group Ltd and BD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Lab Automation for In-vitro Diagnostics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Automated Plate Handler
Automated Liquid Handler
Robotic Arm
Others
Segmentation by application
Academic
Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cognex Corporation
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc
Danaher Corporation
Agilent Technologies, Inc
Abbott
PerkinElmer, Inc
Tecan Group Ltd
BD
Siemens
Key Questions Addressed in this Report
What is the 10-year outlook for the global Lab Automation for In-vitro Diagnostics market?
What factors are driving Lab Automation for In-vitro Diagnostics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lab Automation for In-vitro Diagnostics market opportunities vary by end market size?
How does Lab Automation for In-vitro Diagnostics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lab Automation for In-vitro Diagnostics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Lab Automation for In-vitro Diagnostics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Lab Automation for In-vitro Diagnostics by Country/Region, 2018, 2022 & 2029
2.2 Lab Automation for In-vitro Diagnostics Segment by Type
2.2.1 Automated Plate Handler
2.2.2 Automated Liquid Handler
2.2.3 Robotic Arm
2.2.4 Others
2.3 Lab Automation for In-vitro Diagnostics Sales by Type
2.3.1 Global Lab Automation for In-vitro Diagnostics Sales Market Share by Type (2018-2023)
2.3.2 Global Lab Automation for In-vitro Diagnostics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Lab Automation for In-vitro Diagnostics Sale Price by Type (2018-2023)
2.4 Lab Automation for In-vitro Diagnostics Segment by Application
2.4.1 Academic
2.4.2 Laboratory
2.4.3 Others
2.5 Lab Automation for In-vitro Diagnostics Sales by Application
2.5.1 Global Lab Automation for In-vitro Diagnostics Sale Market Share by Application (2018-2023)
2.5.2 Global Lab Automation for In-vitro Diagnostics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Lab Automation for In-vitro Diagnostics Sale Price by Application (2018-2023)
3 Global Lab Automation for In-vitro Diagnostics by Company
3.1 Global Lab Automation for In-vitro Diagnostics Breakdown Data by Company
3.1.1 Global Lab Automation for In-vitro Diagnostics Annual Sales by Company (2018-2023)
3.1.2 Global Lab Automation for In-vitro Diagnostics Sales Market Share by Company (2018-2023)
3.2 Global Lab Automation for In-vitro Diagnostics Annual Revenue by Company (2018-2023)
3.2.1 Global Lab Automation for In-vitro Diagnostics Revenue by Company (2018-2023)
3.2.2 Global Lab Automation for In-vitro Diagnostics Revenue Market Share by Company (2018-2023)
3.3 Global Lab Automation for In-vitro Diagnostics Sale Price by Company
3.4 Key Manufacturers Lab Automation for In-vitro Diagnostics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lab Automation for In-vitro Diagnostics Product Location Distribution
3.4.2 Players Lab Automation for In-vitro Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lab Automation for In-vitro Diagnostics by Geographic Region
4.1 World Historic Lab Automation for In-vitro Diagnostics Market Size by Geographic Region (2018-2023)
4.1.1 Global Lab Automation for In-vitro Diagnostics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Lab Automation for In-vitro Diagnostics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Lab Automation for In-vitro Diagnostics Market Size by Country/Region (2018-2023)
4.2.1 Global Lab Automation for In-vitro Diagnostics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Lab Automation for In-vitro Diagnostics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Lab Automation for In-vitro Diagnostics Sales Growth
4.4 APAC Lab Automation for In-vitro Diagnostics Sales Growth
4.5 Europe Lab Automation for In-vitro Diagnostics Sales Growth
4.6 Middle East & Africa Lab Automation for In-vitro Diagnostics Sales Growth
5 Americas
5.1 Americas Lab Automation for In-vitro Diagnostics Sales by Country
5.1.1 Americas Lab Automation for In-vitro Diagnostics Sales by Country (2018-2023)
5.1.2 Americas Lab Automation for In-vitro Diagnostics Revenue by Country (2018-2023)
5.2 Americas Lab Automation for In-vitro Diagnostics Sales by Type
5.3 Americas Lab Automation for In-vitro Diagnostics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lab Automation for In-vitro Diagnostics Sales by Region
6.1.1 APAC Lab Automation for In-vitro Diagnostics Sales by Region (2018-2023)
6.1.2 APAC Lab Automation for In-vitro Diagnostics Revenue by Region (2018-2023)
6.2 APAC Lab Automation for In-vitro Diagnostics Sales by Type
6.3 APAC Lab Automation for In-vitro Diagnostics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lab Automation for In-vitro Diagnostics by Country
7.1.1 Europe Lab Automation for In-vitro Diagnostics Sales by Country (2018-2023)
7.1.2 Europe Lab Automation for In-vitro Diagnostics Revenue by Country (2018-2023)
7.2 Europe Lab Automation for In-vitro Diagnostics Sales by Type
7.3 Europe Lab Automation for In-vitro Diagnostics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lab Automation for In-vitro Diagnostics by Country
8.1.1 Middle East & Africa Lab Automation for In-vitro Diagnostics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Lab Automation for In-vitro Diagnostics Revenue by Country (2018-2023)
8.2 Middle East & Africa Lab Automation for In-vitro Diagnostics Sales by Type
8.3 Middle East & Africa Lab Automation for In-vitro Diagnostics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lab Automation for In-vitro Diagnostics
10.3 Manufacturing Process Analysis of Lab Automation for In-vitro Diagnostics
10.4 Industry Chain Structure of Lab Automation for In-vitro Diagnostics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lab Automation for In-vitro Diagnostics Distributors
11.3 Lab Automation for In-vitro Diagnostics Customer
12 World Forecast Review for Lab Automation for In-vitro Diagnostics by Geographic Region
12.1 Global Lab Automation for In-vitro Diagnostics Market Size Forecast by Region
12.1.1 Global Lab Automation for In-vitro Diagnostics Forecast by Region (2024-2029)
12.1.2 Global Lab Automation for In-vitro Diagnostics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lab Automation for In-vitro Diagnostics Forecast by Type
12.7 Global Lab Automation for In-vitro Diagnostics Forecast by Application
13 Key Players Analysis
13.1 Cognex Corporation
13.1.1 Cognex Corporation Company Information
13.1.2 Cognex Corporation Lab Automation for In-vitro Diagnostics Product Portfolios and Specifications
13.1.3 Cognex Corporation Lab Automation for In-vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Cognex Corporation Main Business Overview
13.1.5 Cognex Corporation Latest Developments
13.2 F. Hoffmann-La Roche Ltd
13.2.1 F. Hoffmann-La Roche Ltd Company Information
13.2.2 F. Hoffmann-La Roche Ltd Lab Automation for In-vitro Diagnostics Product Portfolios and Specifications
13.2.3 F. Hoffmann-La Roche Ltd Lab Automation for In-vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 F. Hoffmann-La Roche Ltd Main Business Overview
13.2.5 F. Hoffmann-La Roche Ltd Latest Developments
13.3 Thermo Fisher Scientific Inc
13.3.1 Thermo Fisher Scientific Inc Company Information
13.3.2 Thermo Fisher Scientific Inc Lab Automation for In-vitro Diagnostics Product Portfolios and Specifications
13.3.3 Thermo Fisher Scientific Inc Lab Automation for In-vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Thermo Fisher Scientific Inc Main Business Overview
13.3.5 Thermo Fisher Scientific Inc Latest Developments
13.4 Danaher Corporation
13.4.1 Danaher Corporation Company Information
13.4.2 Danaher Corporation Lab Automation for In-vitro Diagnostics Product Portfolios and Specifications
13.4.3 Danaher Corporation Lab Automation for In-vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Danaher Corporation Main Business Overview
13.4.5 Danaher Corporation Latest Developments
13.5 Agilent Technologies, Inc
13.5.1 Agilent Technologies, Inc Company Information
13.5.2 Agilent Technologies, Inc Lab Automation for In-vitro Diagnostics Product Portfolios and Specifications
13.5.3 Agilent Technologies, Inc Lab Automation for In-vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Agilent Technologies, Inc Main Business Overview
13.5.5 Agilent Technologies, Inc Latest Developments
13.6 Abbott
13.6.1 Abbott Company Information
13.6.2 Abbott Lab Automation for In-vitro Diagnostics Product Portfolios and Specifications
13.6.3 Abbott Lab Automation for In-vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Abbott Main Business Overview
13.6.5 Abbott Latest Developments
13.7 PerkinElmer, Inc
13.7.1 PerkinElmer, Inc Company Information
13.7.2 PerkinElmer, Inc Lab Automation for In-vitro Diagnostics Product Portfolios and Specifications
13.7.3 PerkinElmer, Inc Lab Automation for In-vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 PerkinElmer, Inc Main Business Overview
13.7.5 PerkinElmer, Inc Latest Developments
13.8 Tecan Group Ltd
13.8.1 Tecan Group Ltd Company Information
13.8.2 Tecan Group Ltd Lab Automation for In-vitro Diagnostics Product Portfolios and Specifications
13.8.3 Tecan Group Ltd Lab Automation for In-vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Tecan Group Ltd Main Business Overview
13.8.5 Tecan Group Ltd Latest Developments
13.9 BD
13.9.1 BD Company Information
13.9.2 BD Lab Automation for In-vitro Diagnostics Product Portfolios and Specifications
13.9.3 BD Lab Automation for In-vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 BD Main Business Overview
13.9.5 BD Latest Developments
13.10 Siemens
13.10.1 Siemens Company Information
13.10.2 Siemens Lab Automation for In-vitro Diagnostics Product Portfolios and Specifications
13.10.3 Siemens Lab Automation for In-vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Siemens Main Business Overview
13.10.5 Siemens Latest Developments
14 Research Findings and Conclusion